These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4969143)

  • 21. [Clinical analysis of 41 cases of pulmonary atypical mycobacteriosis].
    Xia XX
    Zhonghua Jie He He Hu Xi Za Zhi; 1992 Aug; 15(4):200-1, 253. PubMed ID: 1307510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rifampicin and ethambutol in the treatment of drug resistant and far advanced pulmonary tuberculosis (with a note on capreomycin).
    Pines A; Raafat H; Siddiqui GM
    J Ir Med Assoc; 1970 Mar; 63(393):82-5. PubMed ID: 4984340
    [No Abstract]   [Full Text] [Related]  

  • 23. Efficacy of clarithromycin and ethambutol for Mycobacterium avium complex pulmonary disease. A preliminary study.
    Miwa S; Shirai M; Toyoshima M; Shirai T; Yasuda K; Yokomura K; Yamada T; Masuda M; Inui N; Chida K; Suda T; Hayakawa H
    Ann Am Thorac Soc; 2014 Jan; 11(1):23-9. PubMed ID: 24298907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antitubercular activity of quinolizidinyl/pyrrolizidinylalkyliminophenazines.
    Tonelli M; Novelli F; Tasso B; Sparatore A; Boido V; Sparatore F; Cannas S; Molicotti P; Zanetti S; Parapini S; Loddo R
    Bioorg Med Chem; 2014 Dec; 22(24):6837-45. PubMed ID: 25464882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative bacteriology in the clinical testing of new antituberculosis drugs.
    Wallace AT
    Tubercle; 1969 Mar; 50():Suppl:47-9. PubMed ID: 4990183
    [No Abstract]   [Full Text] [Related]  

  • 26. Primary drug resistance: a continuing study of drug resistance in tuberculosis in a veteran population within the United States. X. September 1970 to September 1973.
    Hobby GL; Johnson PM; Boytar-Papirnyik V
    Am Rev Respir Dis; 1974 Jul; 110(1):95-8. PubMed ID: 4209360
    [No Abstract]   [Full Text] [Related]  

  • 27. Newer and second-line drugs in the treatment of drug-resistant tuberculosis in children.
    Steiner M
    Med Clin North Am; 1967 Sep; 51(5):1153-67. PubMed ID: 4297572
    [No Abstract]   [Full Text] [Related]  

  • 28. Ethambutol and capreomycin in the re-treatment of advanced pulmonary tuberculosis.
    Lim BT; Aquinas M
    Am Rev Respir Dis; 1969 May; 99(5):792-3. PubMed ID: 4977179
    [No Abstract]   [Full Text] [Related]  

  • 29. The chemotherapy of pulmonary tuberculosis: a review.
    Fox W
    Chest; 1979 Dec; 76(6 Suppl):785-96. PubMed ID: 92393
    [No Abstract]   [Full Text] [Related]  

  • 30. Chemotherapy of chronic pulmonary tuberculosis with polyresistant bacteria with reference to ethambutol and capreomycin.
    Radenbach KL
    Scand J Respir Dis Suppl; 1968; 65():195-206. PubMed ID: 4978461
    [No Abstract]   [Full Text] [Related]  

  • 31. Mycobacterium tuberculosis and nontuberculous mycobacterial isolates among patients with recent HIV infection in Mozambique.
    Nunes EA; De Capitani EM; Coelho E; Panunto AC; Joaquim OA; Ramos Mde C
    J Bras Pneumol; 2008 Oct; 34(10):822-8. PubMed ID: 19009216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of tuberculosis. The Mitchell lecture 1979.
    Mitchison DA
    J R Coll Physicians Lond; 1980 Apr; 14(2):91-5, 98-9. PubMed ID: 6767845
    [No Abstract]   [Full Text] [Related]  

  • 33. Primary drug resistance in children. Drug susceptibility of strains of M. tuberculosis isolated from children during the years 1969 to 1972 at the Kings County Hospital Medical Center of Brooklyn.
    Steiner P; Rao M; Goldberg R; Steiner M
    Am Rev Respir Dis; 1974 Jul; 110(1):98-100. PubMed ID: 4209361
    [No Abstract]   [Full Text] [Related]  

  • 34. Dosing ethambutol in obese patients.
    Alffenaar JW; van der Werf T
    Antimicrob Agents Chemother; 2010 Sep; 54(9):4044; author reply 4044-5. PubMed ID: 20716782
    [No Abstract]   [Full Text] [Related]  

  • 35. First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol.
    Research Committee of the British Thoracic Society
    Thorax; 2001 Mar; 56(3):167-72. PubMed ID: 11182006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Early results of ethambutol treatment in patients with cavernous pulmonary tuberculosis and resistance to many antitubercular agents].
    Kamińska M; Czajka-Kropaczek L; Ciechanowska A
    Gruzlica; 1971 Jul; 39(7):648-52. PubMed ID: 5000657
    [No Abstract]   [Full Text] [Related]  

  • 37. [Prognostic value of isolation of drug-resistant Mycobacterium tuberculosis].
    Astionenko AA
    Vrach Delo; 1978 Dec; (12):27-30. PubMed ID: 105475
    [No Abstract]   [Full Text] [Related]  

  • 38. Tuberculosis in Acukland.
    Swinburn PD
    N Z Med J; 1973 Dec; 78(505):520-5. PubMed ID: 4205888
    [No Abstract]   [Full Text] [Related]  

  • 39. Short-course treatment regimens for patients with tuberculosis.
    Dutt AK; Stead WW
    Arch Intern Med; 1980 Jun; 140(6):827-9. PubMed ID: 6770770
    [No Abstract]   [Full Text] [Related]  

  • 40. Drug resistance among acid-fast bacilli.
    Kato-Maeda M; Sifuentes-Osornio J; Bobadilla-del-Valle M; Ruiz-Palacios GM; Ponce-de-León A
    Lancet; 1999 May; 353(9165):1709. PubMed ID: 10335816
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.